##
|||Page||
|---|---|---|---|
|Reference and Administrative
Details||||
|Report ol'the Trustees|2|to|l0|
|Report ofthe Independent
Auditors|ii|to|l3|
|Statement ofFinancial Activities||14||
|Balance Sheet||i5||
|Cash Flow Statement||l6||
|Notes to the Cash Flow Statement||l7||
|Notes to the Financial Statements|18|to|27|
|TRUSTEES|TRUSTEES||IJ Armstrong||||||
|---|---|---|---|---|---|---|---|---|
||||K Yeowan||||||
||||STownsley||||||
||||TYeldham||||||
|Thc nnstecs|are collectively|refcrrcd to as both 0ยป board|oftrustees
and the|Manaaemcm||Committee.|They are also directors|for the purposes of the|
|Companies|Act.||||||||
|REGISTEREDOFFICE|||Unit 1,Newton|Business||Centre|||
||||Newton
Chambers||Road,|Thomcliffe|Park||
||||Chapeltown||||||
||||SheAield||||||
||||S352PH||||||
|REGISTERED COMPANY NUMBER|||06268494 (England||and Wales)||||
|REGISTEREDCHARITY NUMBER|||1120756||||||
|AUDITORS|||Wyatt, Morris,|Golland Ltd|||||
||||Statutory
Auditors||||||
||||Park House||||||
||||200 Drake Street||||||
||||Rochdale||||||
||||Lancashire||||||
||||OL16 IPJ||||||
|FINANCE OFFICER|||SClayton||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Unrestricted|funds|1,424,252|
|---|---|---|
|Restricted|funds|39,895|
|Total funds||l,464,147|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||FO|RTHE YEAR|ENDED 30APRIL|2022|||
|---|---|---|---|---|---|---|
||||||2022|2021|
||||Unrestricted|Restricted|Total|Total|
||||funds|fimds|funds|funds|
|||Notes|||||
|INCOME AND ENDOWMENTS FROM|||||||
|Donations
and legacies|||488,636|50,000||472,241|
|Other trading activities|||186,000||186,000||
|Invesunent
income|||4,402||4,402|4,&31|
|Total|||679,038|50,000|729,038|477,072|
|EXPENDITURE ON|||||||
|Raising funds|||17/10||17/10|33,940|
|Charitable
activities|||||||
|Charitable
activities|||381,686|83,700||513,985|
|Total|||399,496|$3,700|4&3,196|547,925|
|Net gains/(losses)
on investments|||(111,132)||(111,132)|261,781|
|NET INCOME/(EXPENDITURE)|||168,410|(33,700)|134,710|190,928|
|Transfers
between
I'unds||17|(64,814)|64414|||
|Net movement
in funds|||103896|31,114|134,710|190,928|
|RECONCILIATION|OF FUNDS||||||
|Total funds brought
forward|||1320,656|8,7$1|1329,437|1,138,509|
|TOTAL FUNDS CARRIED FORWARD|||1,4244,52|39+95|1,464,147|1,329,437|
##
##
||30A|PRIL 2022||||
|---|---|---|---|---|---|
|||||2022|2021|
|||Unrestricted|Restricted|Total|Total|
||Notes|funds
f|funds|fundsf|funds
f|
|FIXEDASSETS||||||
|Tangible assets
Investments|12
13|24,749
1,051~1|39~|24,749
1,091,126|27,268
1,208,251|
|||1,075,980|39495|1,115/75|1,235819|
|CURRENT ASSETS
Stocks|14|7488||7~|9,789|
|Debtors|15|129,792||129,792|46,399|
|Cash at bank and in hand||289,125||289,125|173,492|
|||42~05||426405|229,6&0|
|CREDITORS||||||
|Ainounts
falling due within one year|16|(77,933)||(77rt33)|(135,762)|
|NET CURRENT ASSETS|||||93,918|
|TOTAL ASSETSLESSCURRENT LIABILITIES||1,424/52|39/95|1,464,147|1,329,437|
|NET ASSETS||1,424/52|39/95|1,464,147|1,329,437|
|FUNDS|17|||||
|Unrestricted
funds||||1,424~2|1,320,656|
|Restricted
funds||||39~5|8,781|
|TOTAL FUNDS||||1,464,147|1,329,437|
##
|||||2022|2021|
|---|---|---|---|---|---|
||||Notes||E|
|Cash flows from operating activities||||||
|Cash generated
from operations||||116/31|52,804|
|Net cash provided
by operating
activities||||116,831|52,804|
|Cash flows from investing|activities|||||
|Purchase oftangible
fixed|assets|||(7/51)|(17,992)|
|Purchase offixed asset investments||||(52,820)|(832,450)|
|Saleoffixed asset investments||||58/13|839,600|
|Interest received||||160|217|
|Net cash used in investing|activities|||(1,198)|(10,625)|
|Change
in cash and cash|equivalents|in the||||
|reporting
period||||115,633|42,179|
|Cash and cash equivalents|at the beginning of|||||
|the reporting
period||||173,492|131,313|
|Cash and cash equivalents|at the end|ofthe||||
|reporting
period||||289,125|173,492|
##
##
##
||||NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30APRIL 2022|NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30APRIL 2022|||
|---|---|---|---|---|---|---|
|RECONCILIATION|||OF NET INCOME TO NET CASH FLOW FROM OPERATING||ACTIVITIES||
||||||2022|2021f|
|Net income|for the|reporting||period (as per the Statement ofFinancial|||
|Activities)|||||134,710|190,928|
|Adjustments|for:||||||
|Depreciation|charges||||9,153|6,435|
|Losses/(gain)|on investments||||111&132|(261,78I)|
|Loss on disposal offixed assets|||||717|730|
|Interest received
Decrease in stocks|||||(160)
2~1|(217)
10,237|
|(Increase)/decrease||in|debtors||(83/93)|83,226|
|(Decrease)/increase||in|creditors||(57,829)|23,246|
|Nct cash provided||by|operations||116/31|52,804|
|ANALYSIS|OFCHANGES IN NET FUNDS||||||
|||||At 1.5.21|Cash flow|At30.422|
|||||f|f|8|
|Net cash|||||||
|Cash at bank|and in|hand||173,492|115,633|289,125|
|||||173,492|115,633|289,125|
|Total||||173,492|115,633|289,125|
##
##
##
##
##
##
##
##
##
|DONATI|ONS
AND LEGACIES|||
|---|---|---|---|
|||2022f|2021
f|
|Donations||165,815|167,004|
|Legacies||85,694||
|Grants||80,000|75,519|
|Donations|received from PHA (UK)|200,027|214,632|
|Donation|in lieu ofhonorariuin||1,304|
|Emphasis|10Licence fees||4,500|
|Other income||5,777|6,650|
|Furlough|income|1/23|2,632|
|||538,636|472,241|
##
|||2022f|2021
f,|
|---|---|---|---|
|Actelian|||10,000|
|Bayer||10,000|23,915|
|GSK|||11,500|
|South Yorkshire Covid 19|||4,008|
|Merck Sharp Dohm Covid19||10,000|9,048|
|Smiths|||8,000|
|Lottery|||9,048|
|Janssen||60,000||
|||80,000|75,519|
|OTHER|TRADING ACTIVITIES|||
|||2022f|2021f|
|Emphasis|10licence fees|186,000||
##
|||2022|2021f|
|---|---|---|---|
|Investment|income|4/42|4,614|
|Deposit account interest||160|217|
|||4,402|4,831|
|RAISING|FUNDS|||
|Raising donations and legacies||||
|||2022|2021|
|Commissions
and fundraising||8W3|23,836|
|Fundraising|costs|8,917|10,104|
|||17/10|33,940|
##
##
|||||||Support||
|---|---|---|---|---|---|---|---|
||||||Direct|costs (see||
||||||Costs
f|note 7)
f|Totalsf|
|Charitable
activities|||||263,444|201842|465/86|
|SUPPORT COSTS||||||||
|||||||Governance||
||||Management
f||Finance|costs|Totals
f|
|Charitable
activities||||169422|9,797|22/23|201,942|
|NET INCOME/(EXPENDITURE)||||||||
|Net income/(expenditure)|is stated atter charging/(crediting):|||||||
|||||||2022f|2021
f|
|Auditors
remuneration||||||5,700|5,600|
|Depreciation - owned assets||||||9,153|6,435|
|Deficit on disposal offixed assets||||||717|730|
|Auditors
remuneration|non audit work|||||5,781|5,461|
|TRUSTEES' REMUNERATION
There were no~' remuneration||AND BENEFITS
or other benefits|for|the year ended 30th April 2022, nor for the year ended 30th
A||||
|2021.||||||||
|Trustees Expenses:||||||||
|||||||2022|2021|
||||||||f|
|Amounts
paid to trustees||||||51,422|51,473|
##
##
##
##
##
##
##
##
|STAFFCOSTS||||||
|---|---|---|---|---|---|
|||||2022f|2021f|
|Wages and salaries||||59/51|64,740|
|Social security costs||||1/50|1,404|
|Other pension costs||||964|1,183|
|||||61,465|67,327|
|The average monthly
number|ofemployees||during the year was as follows:|||
|||||2022|2021|
|Administration||||2|3|
|No employees
received emoluments||in excess off60,000.||||
|The salaries ofkey personnel|in the|year were f34/15 (2021 - f33,754).||||
|COMPARATIVES FORTHE STATEMENT OF FINANCIAL ACTIVITIES||||||
||||Unrestricted|Restricted|Total|
||||fundsf|funds|fundsf|
|INCOME AND ENDOWMENTS||FROM||||
|Donations
and legacies|||447,278|24,963|472,241|
|investment
income|||4,831||4,831|
|Total|||452,109|24,963|477,072|
|EXPENDITURE ON||||||
|Raising funds|||33,940||33,940|
|Charitable
activities||||||
|Charitable
activities|||390,890|123,095|513,985|
|Total|||424,830|123,095|547,925|
|Net gains on investments|||261,781||261,781|
|NET INCOME/(EXPENDITURE)|||289,060|(98,132)|190,928|
|Transfers
between funds|||(47,214)|47,214||
|Net movement
ln funds|||241,846|(50,918)|190,928|
|RECONCILIATION OF FUNDS||||||
|Total funds brought
forward|||1,078,810|59,699|1,138,509|
|TOTAL FUNDS CARRIED FORWARD|||1,320,656|8,781|1,329,437|
##
##
##
|12,|TANGIBLE FIXEDASSETS||||
|---|---|---|---|---|
|||Fixtures|||
|||and|Oflice||
|||fittings|equipment|Totals|
||||K||
||COST||||
||At I May 2021|11,916|44499|56/15|
||Additions|1,637|5,714|7/51|
||Disposals||(4,076)|(4,076)|
||At 30April 2022|13453|46+37|60,090|
||DEPRECIATION||||
||At I May 2021|6,634|22,913|29~7|
||Charge for year|1&038|8,115|9,153|
||Eliminated
on disposal||(3459)|(3/59)|
||At 30April 2022|7,672|27,669|35/41|
||NET BOOKVALUE||||
||At 30April 2022|5I|18468|24,749|
||At 30April 2021|5,282|21,986|27,268|
|13.|FIXEDASSETINVESTMENTS||||
||||I.isted|Listed|
||||Investments|Invesunents|
||||2022|2021|
||||f||
||Market value at 1stMay 2021||1,208,251|953,620|
||Additions||52,820|832,450|
||Disposals||( 58,813)|(839,600)|
||Unrealised
(loss)/gain||(112,572)|251,276|
||Realised gain||1,440|10/05|
||Mmket value at 30th April 2022||1,091,126|1,208,251|
||Historical
cost at 1stMay 2021||928,553|636,972|
||Addition||52,820|832,450|
||Disposals||(60,186)|(540,869)|
||Historical
cost at 30th April 2022||921,187|928,553|
##
##
|STOCKS|||||
|---|---|---|---|---|
||||2022|2021|
|Stocks|||7~|9,789|
|DEBTORS:AMOUNTS FALLING DUE WITHIN ONE YEAR|||||
||||2022|2021|
|||||f.|
|Trade debtors|||13,159|4,853|
|Other debtors|||14||
|Pulmonary
Hypertension|||||
|Association (UK)|||80,719|20,693|
|Accrued income|||10,673|3,378|
|Prepayments|||25/27|17,475|
||||]29,792|46,399|
|CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR|||||
||||2022|2021|
|Trade creditors|||22,402|16,356|
|Social security and other taxes|||3,157|2,135|
|Accruals and deferred income|||52/74|117/71|
||||77,933|135,762|
|MOVEMENT IN FUNDS|||||
|||Net|Transfers||
|||movement|between|At|
||At 1.5.2l|in tunds|funds|30.4.22|
||f|f|||
|Unrestricted
funds|||||
|General
fund|420,656|331450|(228455)|524/51|
|Medical Research|250,000|(54,000)|54,000|250,000|
|Development
and Printing ofBooklets and|||||
|Online content|350,000|(48,265)|48/65|350,000|
|Awareness
Activities|80,000|(17,520)|17/20|80,000|
|Fundraising
Activities|S0,000|(17,594)|17/95|50,001|
|Contingency
Fund|65,000|||6S,000|
|Patient 8.Peer, Education &Support Events|10S,000|(26,061)|26,061|105,000|
||I/20,656|168,410|(64/I4)|1,424/52|
|Restricted funds|||||
|Living with PH
Covid-19 Impact|8,781|(73/95)
39~|64/I 4|39/95|
||8,781|(33,700)|64/14|39/95|
|TOTAL FUNDS|1/29,437|134,710||1,464,147|
##
##
##
|||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|---|
|||resources
f|expended|losses
f.|in funds|
|Unrestricted
funds||||||
|General fund||679,038|(236,056)|(111,132)|331/50|
|Medical Research|||(54,000)||(54,000)|
|Development
and Printing of
Online content|Booklets and||(48/65)||(~65)|
|Awareness
Activities|||(17420)||(I7+20)|
|Fundraising
Activities|||(17494)||(17J94)|
|Patient k.Peer, Education k.Support Events|||(26,061)||(26,061)|
|||679,038|(399,496)|(111,132)|168,410|
|Restricted funds||||||
|Living with PH|||(73/95)||(73495)|
|Covid-19 Impact||50,000|(10,105)||39J!95|
|||50,000|(83,700)||(33,700)|
|TOTAL FUNDS||729,038|(483,196)|(111,132)|134,710|
|Comparatives
for movement|in funds|||||
||||Net|Transfers||
||||movement|between|At|
|||At 1.5.20|in funds|funds|30.4.21|
|||f|f||f|
|Unrestricted
funds||||||
|General fund||17&,8]0|423,850|(182,004)|420,656|
|Medical Research||250,000|(43,856)|43,856|250,000|
|Development
and Printing ofBooldets and||||||
|Online content||3S0,000|(62,934)|62,934|350,000|
|Awareness
Activities||80,000|(36,599)|36,599|80,000|
|Fundraising
Activities||50,000|8,599|(8,599)|50,000|
|Contingency
Fund
Patient 4 Peer, Education 8cSupport Events||65,000
105,000|||65,000
105,000|
|||1,078,810|289,060|(47,214)|1,320,656|
|Restricted funds||||||
|Living with PH||59,699|(50,918)||8,781|
|Breelib Project|||(47,214)|47,214||
|||59,699|(98,132)|47,214|8,781|
|TOTAL FUNDS||1,138,509|190,928||1329,437|
##
##
||Incoming|Resources|Gains and|Movement|
|---|---|---|---|---|
||resources|expended|losses|in funds|
|Unrestricted
funds|||||
|General fund|437,594|(275,525)|261,781|423,850|
|Medical Research|53|(43,909)||(43,856)|
|Development
and Printing ofBooklets and|||||
|Online content||(62,934)||(62,934)|
|Awareness
Activities||(36,599)||(36,599)|
|Fundraising
Activities|14,462|(5,863)||8,599|
||452,109|(424,830)|261,781|289,060|
|Restricted funds|||||
|Living with PH||(50,918)||(50,918)|
|Breelib Project|15,915|(63,129)||(47,214)|
|Lottery Grant|9,048|(9,048)|||
||24,963|(123,095)||(98,132)|
|TOTAL FUNDS|477,072|(547,925)|261,781|190,928|
##
##
##
##
||||2022|||2021||
|---|---|---|---|---|---|---|---|
|||Land &|||Land Ec|||
|Expiry|date:|Building
f||Other|Building
f||Other|
|Within|I to 5years|||||||
|||129,277||14,336|168,060||21,504|
|||129,277||14,336|168,060||21,504|
##
##
##
##